Scotts Miracle-Gro director granted 77 rights

Director Roberto Candelino received additional dividend equivalent rights tied to equity awards, modestly increasing his derivative-based exposure to SMG common shares.

Rhea-AI Filing Summary

SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Candelino Roberto reported acquisition or exercise transactions in this Form 4 filing.

SCOTTS MIRACLE-GRO CO (SMG) reported that director Roberto Candelino received a grant of 77 Dividend Equivalent Rights on September 4, 2026. These rights relate to existing DSU or RSU awards and are economically equivalent to 77 common shares, bringing his directly held Dividend Equivalent Rights to 374.

Insider Trade Summary

Grant/Award: 77 shares

Grant/Award 1 txn

Insider Candelino Roberto

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	77	--	--

Holdings After Transaction: Dividend Equivalent Rights — 374 contracts (Direct)

Footnotes (1)

1. F1. The dividend equivalent rights accrued on DSU or RSU grants and become exercisable proportionately with the DSUs or RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one common share of the Issuer.

Key Figures

Dividend Equivalent Rights granted: 77 rights Dividend Equivalent Rights following transaction: 374 rights Underlying common shares for this grant: 77 common shares

3 metrics

Dividend Equivalent Rights granted 77 rights Grant to director Roberto Candelino on September 4, 2026

Dividend Equivalent Rights following transaction 374 rights Total directly held by Roberto Candelino after the grant

Underlying common shares for this grant 77 common shares Each Dividend Equivalent Right is the economic equivalent of one common share

Key Terms

Dividend Equivalent Rights, DSU, RSU, economic equivalent

4 terms

Dividend Equivalent Rights financial

"The dividend equivalent rights accrued on DSU or RSU grants"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

DSU financial

"The dividend equivalent rights accrued on DSU or RSU grants"

RSU financial

"The dividend equivalent rights accrued on DSU or RSU grants"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one common share"

FAQ

What insider transaction did SMG disclose for Roberto Candelino?

SMG disclosed that director Roberto Candelino received a grant of 77 Dividend Equivalent Rights on September 4, 2026. These rights accrue on his DSU or RSU grants and are economically equivalent to 77 common shares of SMG.

How many dividend equivalent rights does Roberto Candelino hold after this SMG Form 4?

After the reported grant, Roberto Candelino directly holds 374 Dividend Equivalent Rights. Each right is the economic equivalent of one common share and becomes exercisable proportionately with the related DSUs or RSUs.

What are Dividend Equivalent Rights in the context of SMG?

For SMG, Dividend Equivalent Rights accrue on DSU or RSU grants and become exercisable proportionately with those DSUs or RSUs. Each right is described as the economic equivalent of one common share of SCOTTS MIRACLE-GRO CO.

Is the SMG Form 4 transaction a purchase or a grant?

The filing reports a grant or award acquisition of 77 Dividend Equivalent Rights, coded as an acquisition (A) of a derivative security, not an open-market purchase or sale.

Does the SMG Form 4 indicate a Rule 10b5-1 trading plan for this grant?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote stating that the transaction was made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 08:36 AM Accepted by SEC EDGAR 09/09/2026 - 08:36 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Candelino Roberto

(Last) (First) (Middle)

C/O THE SCOTTS MIRACLE-GRO COMPANY

14111 SCOTTSLAWN ROAD

(Street)

MARYSVILLE OHIO 43041

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCOTTS MIRACLE-GRO CO [ SMG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/04/2026		A		77		(1)	(1)	Common Shares	77	(1)	374	D

Explanation of Responses:

1. The dividend equivalent rights accrued on DSU or RSU grants and become exercisable proportionately with the DSUs or RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one common share of the Issuer.

Remarks:

	/s/ Kathy L. Uttley as attorney-in-fact for Roberto Candelino	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)